XML 26 R15.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingencies (Tables)
3 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Schedule of exercisable share purchase warrants outstanding
          
       Weighted
    Number of  Average Exercise
    Shares  Price ($)
Balance, September 30, 2020   500,000    3.88 
Granted   60,000    12.00 
Exercised   (350,000)   4.19 
Balance, September 30, 2021   210,000    5.69 
Forfeited   (50,000)   12.00 
Balance, December 31, 2021   160,000    3.72 
Schedule of share purchase warrants outstanding
          
Number  Exercise Price  Expiry Date
 150,000   $3.17   May 6, 2024
 10,000   $12.00   April 21, 2026
 160,000         

 

Schedule of outstanding stock purchase options
                    
       Weighted  Weighted   
       Average  Average Grant  Aggregate
    Number of  Exercise Price  Date Fair  intrinsic value
    Shares  ($)  Value ($)  ($)
Outstanding, September 30, 2020   10,076,266    3.48         14,982,581 
Granted   2,732,000    12.55    9.32      
Forfeited   (55,834)   3.04    2.43      
Exercised   (1,421,529)   2.89    2.43    24,446,305 
Outstanding, September 30, 2021   11,330,903    5.74         140,132,451 
Granted   50,000    19.64    15.52      
Exercised   (137,134)   2.72    2.12    2,276,948 
Outstanding, December 31, 2021   11,243,769    5.84         132,001,363 
Exercisable, December 31, 2021   8,294,684    3.75         112,870,598 

Schedule Of Share-based Payment Arrangement, Option, Activity
                                
         Weighted         
         average  Weighted     Weighted
Range of exercise  Number of  remaining  average     average
prices  outstanding  contractual  exercise  Number of  exercise
From  To  options  life (in years)  price  vested options  price
$0.92   $2.96    4,172,215    5.94    2.29    4,049,714    2.29 
$3.15   $4.80    2,117,500    6.08    3.30    1,837,500    3.29 
$5.04   $8.98    3,397,054    6.20    6.05    2,347,054    6.30 
$12.00   $13.01    230,000    9.27    12.44    39,166    12.38 
$17.03   $24.58    1,327,000    9.58    19.35    21,250    24.24 
           11,243,769              8,294,684      
Schedule of general and administrative expenses and research and development expenses
          
   2021  2020
General and administrative  $1,671,726   $422,823 
Research and development   2,237,046    516,491 
Total stock-based compensation  $3,908,771   $939,314 
Schedule of weighted average assumptions for fair value of each option award
          
   2021  2020
Risk-free interest rate   1.37%   0.62%
Expected life of options (years)   6.50    5.59 
Annualized volatility   96.79%   96.16%
Dividend rate   0.00%   0.00%